Immunotherapy in Acute Leukemia
Recent advances in immunotherapy of cancer may represent a successful example in translational research, in which progress in knowledge and technology in immunology has led to new strategies of immunotherapy, and even past failures in many clinical trials have led to a better understanding of basic cancer immunobiology. This article reviews the latest concepts in antitumor immunology and its application in the treatment of cancer, with particular focus on acute leukemia.
To access this article, please choose from the options below
Supported in part by National Institutes of Health Grant No. P30CA21765-24, the Assisi Foundation of Memphis, and the American Lebanese Syrian Associated Charities (ALSAC).
PII: S0037-1963(08)00147-9
doi:10.1053/j.seminhematol.2008.09.004
© 2009 Elsevier Inc. All rights reserved.
